Health

Markets Slip Amid Geopolitical Tensions and Fed Uncertainty

S&P 500 logs third straight loss as rate cut timeline and Middle East risks weigh on sentiment The S&P 500 slipped 0.22% on Friday to close at 5,967.84, marking its...

Accenture Drops 7% Despite Revenue Beat and Raised Outlook

Investors focus on falling bookings and growth concerns Shares of Accenture (NYSE: ACN) slid 6.8% to close at $285.49...

Canada Threatens Tariff Hike as US Trade Talks Stall

Steel and aluminum tariffs may rise if no deal is reached by July Canada warned on Thursday it could...

Fed Holds Rates Steady as Markets Watch Iran Tensions

Stocks mixed as investors weigh Fed outlook and geopolitics U.S. markets ended mixed on Wednesday as the Federal Reserve...

Thailand Seeks U.S. Tariff Deal as Exports Surge in May

Proposal to reduce tariffs and boost U.S. trade to be submitted Friday Thailand held critical trade discussions with the...
spot_img

Lyme Disease Cases Surge in the US Due to Reporting Changes

Lyme disease cases in the United States saw a dramatic spike of nearly 70% in 2022, a revelation attributed not to a sudden surge...

New Death Brings Focus to Alaskapox: Understanding the Rare Virus

In a remote corner of Alaska, a recent tragedy has drawn attention to a little-known virus lurking in the wilderness. The death of an...

Medical Journal Retracts Studies on Abortion Pill Due to Flaws and Conflicts of Interest

A significant development has emerged in the ongoing debate over the abortion pill mifepristone, as two studies claiming to demonstrate its harms have been...

Ecuador Identifies Source of Tainted Cinnamon in U.S. Child Poisoning Cases

Ecuadorian authorities have pinpointed the source of contaminated ground cinnamon believed to be responsible for a concerning outbreak of lead poisoning in American children....

Dental Association Shifts Guidelines: Lead Aprons No Longer Recommended for X-rays

In a significant departure from conventional practices, the American Dental Association (ADA) has announced that it will no longer recommend the use of lead...

Biogen Announces Halt to Aduhelm Sales and Development

Cambridge, Massachusetts-based pharmaceutical company Biogen has made a significant decision regarding its Alzheimer's drug, Aduhelm. The drug, once hailed as a potential blockbuster, is...